245 related articles for article (PubMed ID: 9930386)
21. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
[TBL] [Abstract][Full Text] [Related]
23. Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.
Richter JE
Am J Med; 2003 Aug; 115 Suppl 3A():179S-187S. PubMed ID: 12928099
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
25. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
[TBL] [Abstract][Full Text] [Related]
26. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.
Waldum HL; Qvigstad G; Fossmark R; Kleveland PM; Sandvik AK
Scand J Gastroenterol; 2010 Apr; 45(4):389-94. PubMed ID: 20001749
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
[TBL] [Abstract][Full Text] [Related]
28. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
29. Proton-pump inhibitors for gastric acid-related disease.
Franko TG; Richter JE
Cleve Clin J Med; 1998 Jan; 65(1):27-34. PubMed ID: 9465453
[TBL] [Abstract][Full Text] [Related]
30. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
Orr WC; Mellow MH; Grossman MR
Aliment Pharmacol Ther; 1995 Oct; 9(5):571-4. PubMed ID: 8580280
[TBL] [Abstract][Full Text] [Related]
31. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
32. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
el-Nujumi A; Williams C; Ardill JE; Oien K; McColl KE
Gut; 1998 Feb; 42(2):159-65. PubMed ID: 9536937
[TBL] [Abstract][Full Text] [Related]
33. Current regimens for treatment of Helicobacter pylori infection.
Harris A
Br Med Bull; 1998; 54(1):195-205. PubMed ID: 9604443
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
35. The Effect of H
Shim YK; Kim N
Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310
[TBL] [Abstract][Full Text] [Related]
36. [Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease].
Sohn YH; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ
Korean J Gastroenterol; 2006 Sep; 48(3):162-71. PubMed ID: 17047431
[TBL] [Abstract][Full Text] [Related]
37. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
[TBL] [Abstract][Full Text] [Related]
38. Importance of pH control in the management of GERD.
Hunt RH
Arch Intern Med; 1999 Apr; 159(7):649-57. PubMed ID: 10218743
[TBL] [Abstract][Full Text] [Related]
39. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
40. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism.
Chey WD; Woods M; Scheiman JM; Nostrant TT; DelValle J
Am J Gastroenterol; 1997 Mar; 92(3):446-50. PubMed ID: 9068466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
